We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 275 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8482,031 (+183)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+183
Holders Change %
+9.9%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
275
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
DWT
1076
Dorsey & Whitney Trust
South Dakota
$1.77M +$42.2K +90 +2%
IIM
1077
Intact Investment Management
Quebec, Canada
$1.77M -$188K -400 -10%
MCM
1078
Manchester Capital Management
Vermont
$1.76M +$14.1K +30 +0.8%
PCIG
1079
Partners Capital Investment Group
Massachusetts
$1.76M +$1.77M +3,784 New
PRWA
1080
Platte River Wealth Advisors
Colorado
$1.76M +$4.69K +10 +0.3%
TF
1081
Tompkins Financial
New York
$1.76M -$25.3K -54 -1%
AWM
1082
Altavista Wealth Management
North Carolina
$1.76M -$60K -128 -3%
PFM
1083
Patton Fund Management
Texas
$1.74M -$399K -850 -19%
ACS
1084
Archford Capital Strategies
Illinois
$1.74M +$13.6K +29 +0.9%
FL
1085
Fort LP
Maryland
$1.74M +$162K +346 +10%
WG
1086
Winton Group
United Kingdom
$1.74M -$2.02M -4,303 -54%
CYG
1087
Clean Yield Group
Vermont
$1.73M +$7.97K +17 +0.5%
CNAM
1088
Campbell Newman Asset Management
Wisconsin
$1.72M -$707K -1,508 -29%
CAL
1089
Capital Analysts LLC
Pennsylvania
$1.72M -$485K -1,035 -22%
DBT
1090
Dubuque Bank & Trust
Iowa
$1.72M +$62.4K +133 +4%
FC
1091
Forte Capital
New York
$1.71M -$221K -471 -11%
CT
1092
Cambridge Trust
Massachusetts
$1.7M +$208K +443 +14%
MWM
1093
MBE Wealth Management
Wisconsin
$1.69M +$5.63K +12 +0.3%
JIC
1094
Johnson Investment Counsel
Ohio
$1.69M +$70.3K +150 +4%
NISOA
1095
National Investment Services of America
Wisconsin
$1.69M -$610K -1,301 -26%
TPI
1096
Tesco Pension Investment
United Kingdom
$1.68M -$20.8M -44,273 -11%
AA
1097
AlphaMark Advisors
Kentucky
$1.68M -$1.62M -3,465 -49%
CMANY
1098
Capital Management Associates (New York)
New York
$1.68M
VBCG
1099
Valley Brook Capital Group
Pennsylvania
$1.67M +$1.69M +3,595 New
CWM
1100
Circle Wealth Management
New Jersey
$1.67M +$579K +1,235 +53%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 275 funds opened new TMO positions and 70 closed out — a net gain of 205 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,848 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 275 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +205 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.